LEGN Stock Analysis: Buy, Sell, or Hold?
LEGN - Legend Biotech Corporation American Depositary Shares
$17.50
-0.22 (-1.24%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 10, 2026
Get Alerted When LEGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LEGN is fairly valued with market pricing in 4.4% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: LEGN is fairly valued with market pricing in 4.4% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$8.83
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$5.48
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LEGN is currently trading at $17.50, which is considered oversold relative to its 30-day fair value range of $19.36 to $23.22. From a valuation perspective, the stock is trading at a premium (Forward PE: 70.3) compared to its historical average (61.8). At these levels, the market is pricing in 4.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, LEGN is in a strong downtrend. The price is currently testing key support at $17.03. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $66.32 (+274.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LEGN is in a strong downtrend. The price is currently testing key support at $17.03. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $66.32 (+274.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$19.36 -
$23.22
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.5%
Protect Your Profits
Holding LEGN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 274.3% below Wall St target ($66.32)
- NEUTRAL: Market pricing in 4.4% annual earnings growth - fairly valued
- CAUTION: Recommendation downgraded due to -7.9% 5-day decline
Fair Price Analysis
30-Day Fair Range
$19.36 -
$23.22
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$17.03
Resistance Level
$23.88
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
70.32
Wall Street Target
$66.32
(+274.3%)
Revenue Growth (YoY)
70.0%
Profit Margin
-26.4%
Valuation Premium vs History
+4.4% premium
PE vs Historical
70.3 vs 61.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.4%
(market-implied from PE analysis)
1-Year Target
$18.50
(+4%)
2-Year Target
$19.31
(+9%)
3-Year Target
$20.16
(+14%)
3-Yr Target (if PE normalizes)
(PE: 70→62)
PE COMPRESSION
$17.72
(0%)
Earnings growth offset by PE compression
Last updated: January 30, 2026 9:44 PM ET
Data refreshes hourly during market hours. Next update: 10:44 PM
Data refreshes hourly during market hours. Next update: 10:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LEGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$90 | 59 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$35 | 51 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$65 | 60 HOLD |
Advanced LEGN Option Strategies
Professional options setups generated by AI based on today's LEGN price and gamma walls.
